How many studies have been conducted on Chemokine Ccl5?

BiohacksAI has indexed 260 PubMed studies on Chemokine Ccl5, including 1 randomized controlled trials (RCTs). 28% of studies involve human subjects.

What are the main research areas for Chemokine Ccl5?

The primary research domains for Chemokine Ccl5 are 🔬 Oncology, 🛡️ Immunity, 🔬 Inflammation. This is based on analysis of 260 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Chemokine Ccl5

A CC-type chemokine that is a chemoattractant for EOSINOPHILS; MONOCYTES; and LYMPHOCYTES. It is a potent and selective eosinophil chemotaxin that is stored in and released from PLATELETS and activated T-LYMPHOCYTES. Chemokine CCL5 is specific for CCR1 RECEPTORS; CCR3 RECEPTORS; and CCR5 RECEPTORS. The acronym RANTES refers to Regulated on Activation, Normal T Expressed and Secreted.

260+ PubMed studies analyzed · 1 RCTs · Evidence Score: 45.5

Research Domains

Chemokine Ccl5 has been studied across 18 research domains including 🔬 Oncology, 🛡️ Immunity, 🔬 Inflammation, 🫁 Liver & Detox, ❤️ Cardiovascular. The primary research focus is 🔬 Oncology with 32% of studies addressing this area.

Loading evidence profile...

This evidence profile for Chemokine Ccl5 is generated deterministically from 260 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.